Lipocine
LPCN
#10355
Rank
A$26.43 M
Marketcap
A$3.21
Share price
2.73%
Change (1 day)
-34.05%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: A$26.43 Million

As of June 2026 Lipocine has a market cap of A$26.43 Million. This makes Lipocine the world's 10355th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$26.43 M-39.03%
2025A$43.35 M5.92%
2024A$40.92 M88%
2023A$21.76 M-57.93%
2022A$51.74 M-57.13%
2021A$0.12 B3.89%
2020A$0.11 B461.31%
2019A$20.69 M-48.39%
2018A$40.1 M-57.06%
2017A$93.39 M0.18%
2016A$93.22 M-71.21%
2015A$0.32 B293.79%
2014A$82.23 M-29.82%
2013A$0.11 B

End of Day market cap according to different sources

On Jun 12th, 2026 the market cap of Lipocine was reported to be:

A$26.43 Million
by Nasdaq info icon info icon
A$26.43 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
A$61.22 B 231,516.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A$20.52 B 77,540.49%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
A$14.79 M-44.04%๐Ÿ‡บ๐Ÿ‡ธ USA